| 2021-04 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2021-04 |
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2021-04 |
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2021-04 |
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B |
HEPATOLOGY RESEARCH
|
| 2021-03 |
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization |
Journal of liver cancer (대한간암학회지)
|
| 2021-03 |
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer |
Journal of liver cancer (대한간암학회지)
|
| 2021-03 |
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma |
CANCER INVESTIGATION
|
| 2021-02 |
Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression |
Clinical and Translational Gastroenterology
|
| 2021-02 |
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization |
Current Oncology
|
| 2021-02 |
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-01 |
The cutoff of transient elastography for the evaluation of portal hypertension should be different according to the etiology? |
Clinical and molecular hepatology
|
| 2021-01 |
Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years |
JOURNAL OF DIABETES AND ITS COMPLICATIONS
|
| 2021-01 |
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy |
GUT AND LIVER
|
| 2021-01 |
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma |
YONSEI MEDICAL JOURNAL
|
| 2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion |
Journal of hepatocellular carcinoma
|
| 2020-12 |
Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2020-11 |
Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study |
KOREAN JOURNAL OF INTERNAL MEDICINE
|
| 2020-11 |
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization |
GUT AND LIVER
|
| 2020-11 |
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals |
Cancers
|
| 2020-11 |
Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B |
DIGESTIVE AND LIVER DISEASE
|
| 2020-09 |
Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack |
CEREBROVASCULAR DISEASES
|
| 2020-09 |
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus |
GUT AND LIVER
|
| 2020-09 |
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-09 |
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation |
Cancers
|
| 2020-07 |
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia |
LIVER INTERNATIONAL
|
| 2020-07 |
How does low-level viremia affect the prognosis of patients with chronic hepatitis B? |
Clinical and molecular hepatology
|
| 2020-07 |
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study |
GUT AND LIVER
|
| 2020-07 |
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2020-07 |
Clinical relevance of dynamic risk assessment for developing hepatocellular carcinoma during prolonged antiviral therapy |
JOURNAL OF HEPATOLOGY
|
| 2020-06 |
Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2020-05 |
Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2020-05 |
Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
| 2020-04 |
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications |
Clinical and molecular hepatology
|
| 2020-04 |
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2020-03 |
Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2020-03 |
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
Clinical and Translational Gastroenterology
|
| 2020-03 |
An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-03 |
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-01 |
A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea |
Clinical and molecular hepatology
|
| 2020-01 |
Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study |
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
|
| 2020-01 |
Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection |
Clinical and molecular hepatology
|
| 2020-01 |
Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study |
MODERN RHEUMATOLOGY
|
| 2020-01 |
Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2020-01 |
Autoimmune Hepatic Failure Following Acute Hepatitis A is Accompanied by Inflammatory Conversion of Regulatory T Cells |
YONSEI MEDICAL JOURNAL
|
| 2019-12 |
Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy |
SCIENTIFIC REPORTS
|
| 2019-12 |
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis |
DIGESTIVE DISEASES AND SCIENCES
|
| 2019-12 |
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2019-12 |
Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2019-11 |
The remaining challenges of HCV treatment in the direct-acting antivirals era |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2019-10 |
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis |
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
|
| 2019-10 |
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study |
PLOS ONE
|
| 2019-09 |
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir |
Clinical and molecular hepatology
|
| 2019-09 |
External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy |
LIVER INTERNATIONAL
|
| 2019-09 |
Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation |
CANCER MEDICINE
|
| 2019-09 |
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea |
JOURNAL OF HEPATOLOGY
|
| 2019-08 |
Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2019-08 |
Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma |
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
|
| 2019-06 |
Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2019-06 |
Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals |
Clinical and Translational Gastroenterology
|
| 2019-04 |
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization |
Cancers
|
| 2019-04 |
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma |
BMC CANCER
|
| 2019-04 |
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection |
PLOS ONE
|
| 2019-03 |
Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status |
GUT AND LIVER
|
| 2019-03 |
Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model |
GUT AND LIVER
|
| 2019-03 |
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis |
Journal of Clinical Medicine
|
| 2019-02 |
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals |
SCIENTIFIC REPORTS
|
| 2019-02 |
Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients |
CEREBROVASCULAR DISEASES
|
| 2019-01 |
Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers |
LIVER INTERNATIONAL
|
| 2018-12 |
Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level |
Clinical and molecular hepatology
|
| 2018-09 |
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib |
LIVER INTERNATIONAL
|
| 2018-08 |
Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2018-05 |
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety |
GUT AND LIVER
|
| 2018-04 |
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B |
LIVER INTERNATIONAL
|
| 2018-04 |
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance |
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
|
| 2018-03 |
Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B |
GUT AND LIVER
|